sustainability

Sustainability Overview

Our vision, “to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally", encapsulates the Group’s inherent approach of conducting business ethically, ​​​​​​​with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.

OUR APPROACH TO SUSTAINABILITY

We recognise that doing business in a sustainable manner is integral to ensuring our future viability.  As such sustainability considerations underpin our strategy and  are integrated into our day-to-day-activities.

​​​​​​​Our material sustainability issues are grouped into 10 sustainability objectives which are aligned to the Group’s strategic objectives, the related capitals and the relevant key performance indicators ("KPIs"). The Audit & Risk Committee reviews and approves the sustainability objectives and the related KPIs. The Board monitors the sustainability performance with reference to these KPIs on a regular basis.

Material sustainability issues are determined through ongoing interactions with our key stakeholders with reference to:
• external factors impacting the Group’s business model and pursuit of strategic  objectives;
• key business risks impacting the Group’s sustainability;
• the value exchange and/or opportunity cost of the applied intellectual, manufactured, human, social & relationship, natural and financial capitals to the business as well as the responsible management of these; and
• our responsibility to stakeholders and transparency in reporting with reference to the GRI  Sustainability Reporting Stanards, King IV, Companies Act of South Africa, BBBEE Codes in South Africa, the JSE/FTSE Responsible Investment Index, the Carbon Disclosure Project  and the UN Global Compact.

ASSURANCE

Assurance in respect of the sustainability KPIs is obtained by means of a combined assurance approach, with ERM providing assurance on the key environmental, health and safety indicators in line with the AccountAbility AA1000 Assurance Standard, PwC providing assurance on the financial indicators and other assurance providers such as the Group’s Internal Audit and Empowerdex providing assurance on the balance of the indicators reported.

Contact Details

Jeanette Englund

+27 31 580 8600

JEnglund@aspenpharma.com

Downloads

2017 Supplementary Sustainability Documents

Aspen 2017 Sustainability Data Supplement
PDF 1MB
Equity Report - Fine Chemicals Workforce Profile 2016
PDF 176KB
Equity Report - Pharmacare Workforce Profile 2016
PDF 175.8KB
Aspen 2017 PWC KPI Assurance Report
PDF 1MB
Aspen 2017 ERM Assurance Statement
PDF 166.8KB

2017 Safety and Environmental Certifications

Aspen CDP 2017
PDF 896KB
Aspen CPD Water 2017
PDF 632KB
Aspen Environmental Management Principles
PDF 71KB
Aspen Australia - Dandenong ISO 14001
PDF 402KB
Aspen Australia - Dandenong OHSAS 18001
PDF 402KB
Aspen Pharma - ISO 14001
PDF 314KB
Aspen Pharma - OHSAS 18001
PDF 299KB
Aspen NDB - ISO 14001
PDF 504KB
Aspen NDB - OHSAS 18001
PDF 509KB
Aspen Bad Oldesloe ISO 14001 and ISO 9001
PDF 1MB
Aspen Bad Oldesloe ISO 50001
PDF 1MB
Aspen Bad Oldesloe - OHSAS 18001
PDF 1MB
Aspen South African Operations ISO 14001
PDF 808KB
Aspen South African Operations OHSAS 18001
PDF 791KB
Aspen Bad Oldesloe - OHSAS 18001
PDF 1MB
Aspen Labs - Vallejo ISO 14001
PDF 138KB
Aspen Labs - Vallejo OHSAS 18001
PDF 126KB

Intellectual
Capital

Read more

Manufactured
Capital

Read more

Human
Capital

Read more

Social & Relationship Capital

Read more

Natural
Capital

Read more

Financial
Capital

Read more

Intellectual
Capital

Our intellectual capital supports our focused therapeutic basket of high quality, affordable medicines and products.

Strategic objective

To enhance access to high quality, affordable medicines

Aspen's sustainability objectives

Sustaining life and health through high quality, affordable medicines

Material KPIs

  • IMS Health (Pty) Limited (“IMS”) value of total product pipeline for the next five years
  • Number of product recalls

Assurance provider: Internal Audit

Manufactured Capital

The investment in our API facilities and FDF manufacturing capabilities aimed at delivering integrated and operational synergies is a key enabler in supporting our mission to produce high quality, affordable medicines and products, enhancing access to healthcare in over 150 countries.

Strategic objective

To achieve strategic advantage through our integrated supply chain

Aspen's sustainability objectives

Sustaining a cost-competitive manufacturing base

Material KPIs

  • Return on total assets
  • EBITDA margin

Assurance provider: PwC

Human Capital

Built on the foundation of our values and a commitment to the Group Code of Conduct, we strive to provide a safe, challenging and rewarding environment for each of our employees.

Strategic objective

To provide a safe, challenging and rewarding environment for our employees

Aspen's sustainability objectives

Creating an environment in which our employees can thrive


Providing a safe working environment

Material KPIs

  • Average staff turnover
  • Average training spend per employee

Assurance provider: Internal Audit

  • Disabling incident frequency rate (“DIFR”)#
  • Lost work day frequency rate (“LWDFR”)#

Assurance provider: ERM

# Measured for manufacturing businesses only (does not include New Zealand New Milks).

Social & relationship Capital

Responsible corporate citizenship is more than a compliance requirement, it is fundamental to our objectives and the way we do business. We recognise that there are inseparable linkages between our sustainable growth, our relationships with our stakeholders and its contribution to society in the broader context.

Strategic objective

To practise good corporate citizenship

Aspen's sustainability objectives

Promoting equality
Conducting our business in a responsible manner

Material KPIs

  • Percentage of female employees
  • Percentage of black employees in South Africa

Assurance provider: Internal Audit

  • BBBEE accreditation in South Africa

Assurance provider: ERM

  • Number of material incidents of legislative infringements

2016 assurance provided: Internal Group Compliance officer review

Natural Capital

As a manufacturer of quality medicines, APIs and nutritional products, we are reliant on the conversion and use of natural capital in creating value for its stakeholders. We recognize that our operations directly and indirectly impact the environment and the Aspen Environmental Management Protocol affirms our commitment reducing our impact on the environment, responsible environmental management, conservation and protection across all of our operations.

Strategic objective

To practise good corporate citizenship

Aspen's sustainability objectives

Preserving the environment


Managing the efficient utilisation of scarce resources

Material KPIs

  • Carbon emissions#
  • Waste recycled#

Assurance provider: ERM

  • Water used#
  • Electricity used#

Assurance provider: ERM

# Measured for manufacturing businesses only (does not include New Zealand New Milks).

Financial Capital

We aim to create value for all of our stakeholders, by managing our financial capital in a commercially astute and diligent manner thereby harnessing opportunities for long-term sustainable economic growth.

Strategic objective

To create sustainable economic value for all of our stakeholders

Aspen's sustainability objectives

Adding economic value to stakeholders


Maintenance of financial health

Material KPIs

  • Growth in normalised headline earnings per share (“NHEPS”)
  • Return on ordinary shareholders’ equity
  • Growth in gross revenue
  • Growth in EBITDA
  • Value added per permanent employee
  • Operating cash flow per share
  • Leveraging ratio

Assurance provider: PwC